MIRUM PHARMACEUTICALS, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 24.1 USD | -1.33% |
|
+1.22% | -18.22% |
Chart calendar Mirum Pharmaceuticals, Inc.
e0069cb.ZngU8B1i8JyojSLn06vMIWX0seZHhOBFyItzZTDV6mE.CQkgn3UTiKXj0leGjNm1WQ7M-7IE8IwDruwDUWegsgQHIlKxZSCY1Zq4SQ~cf85a86eff2aa928350e339bbf2199ff
Upcoming events on Mirum Pharmaceuticals, Inc.
Past events on Mirum Pharmaceuticals, Inc.
| 2024-03-12 | Barclays Global Healthcare Conference |
| 2024-03-12 03:00 pm | Leerink Partners Global Biopharma Conference |
| 2024-02-28 04:30 pm | Q4 2023 Earnings Call |
| 2024-02-28 04:03 pm | Q4 2023 Earnings Release |
| 2024-01-10 01:30 pm | JPMorgan Healthcare Conference |
| 2023-11-28 03:25 pm | Evercore ISI HealthCONx Conference |
| 2023-11-13 01:00 pm | American Association for the Study of Liver Diseases Conference - Poster Number - 4547-C |
| 2023-11-13 01:00 pm | American Association for the Study of Liver Diseases Conference - Poster Number - 4605-C |
| 2023-11-13 01:00 pm | American Association for the Study of Liver Diseases Conference - Poster Number - 4604-C |
| 2023-11-13 01:00 pm | American Association for the Study of Liver Diseases Conference - Poster Number - 4602-C |
| 2023-11-13 01:00 pm | American Association for the Study of Liver Diseases Conference - Poster Number - 5048-C |
| 2023-11-08 02:00 pm | UBS BioPharma Conference - Fireside Chat |
| 2023-11-02 04:30 pm | Q3 2023 Earnings Call |
| 2023-11-02 04:05 pm | Q3 2023 Earnings Release |
| 2023-10-07 03:00 pm | North American Society For Pediatric Gastroenterology Hepatology And Nutrition Meeting - Abstract No |
| 2023-10-07 03:00 pm | North American Society For Pediatric Gastroenterology Hepatology And Nutrition Meeting - Abstract No |
| 2023-10-07 03:00 pm | North American Society For Pediatric Gastroenterology Hepatology And Nutrition Meeting - Abstract No |
| 2023-10-07 03:00 pm | North American Society For Pediatric Gastroenterology Hepatology And Nutrition Meeting - Abstract No |
| 2023-10-07 01:30 pm | North American Society For Pediatric Gastroenterology Hepatology And Nutrition Meeting - Abstract 53 |
| 2023-10-06 03:00 pm | North American Society For Pediatric Gastroenterology Hepatology And Nutrition Meeting - Abstract No |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 8,33 - | 19,1 78,4 -75.6% | 77,1 74,1 3.93% | 186 185 0.96% | 316 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | -173 -169 -2.26% | -128 -138 7.01% | 0,00 -101 - | -45,8 |
|
EBIT Million USD | Released Forecast Spread | -54,7 -53,1 -3% | -104 -91,8 -13.67% | -173 -141 -22.67% | -131 -132 0.81% | -107 -95,3 -11.91% | -69,2 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -52,5 -51,7 -1.61% | -103 -90,1 -14.64% | -84,0 -137 38.87% | -142 -145 1.86% | -160 -139 -15.44% | -77,1 |
|
Net income Million USD | Released Forecast Spread | -52,6 -51,7 -1.65% | -103 -90,1 -14.65% | -84,0 -129 34.7% | -136 -137 1.18% | -161 -141 -14.39% | -58,9 |
|
EPS USD | Released Forecast Spread | -4,58 -3,68 -24.46% | -4,09 -3,57 -14.49% | -2,77 -4,51 38.62% | -4,02 -3,92 -2.61% | -3,94 -3,45 -14.18% | -1,13 |
| Announcement Date | 12/03/20 | 09/03/21 | 09/03/22 | 08/03/23 | 28/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 3,14 62,7 -94.99% | 12,9 8,46 52.33% | 17,5 15,4 13.41% | 18,8 20,8 -9.75% | 27,9 25,1 11.27% | 31,6 30,8 2.62% | 37,5 30,4 23.17% | 47,7 38,6 23.66% | 69,6 67,9 2.5% | 70,2 | 75,4 | 82,5 | 89,2 | 94,2 |
|
EBITDA Million USD | Released Forecast Spread | -45,2 -41,0 -10.32% | -32,4 -36,0 10.02% | -30,8 -27,0 -14.23% | -31,4 -32,0 1.74% | -25,8 -27,0 4.4% | -10,0 | -20,4 | -18,5 | -11,9 | -6,12 | ||||
|
EBIT Million USD | Released Forecast Spread | -45,6 -13,1 -247.01% | -32,7 -43,6 24.95% | -31,4 -35,8 12.08% | -32,9 -31,8 -3.51% | -34,2 -32,0 -6.8% | -27,1 -30,7 11.56% | -24,3 -27,6 11.99% | -25,1 -27,9 9.85% | -30,1 -11,3 -165.45% | -25,5 | -23,4 | -17,3 | -12,8 | -3,07 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 57,6 4,37 1217.96% | -36,6 -45,8 20.14% | -33,5 -37,7 11.27% | -35,7 -34,1 -4.66% | -36,3 -38,6 5.91% | -29,9 -33,9 11.65% | -73,7 -29,7 -147.92% | -23,3 -28,4 17.7% | -32,9 -11,2 -194.88% | -26,3 | -25,5 | -17,4 | -14,0 | |
|
Net income Million USD | Released Forecast Spread | 57,5 13,1 339.08% | -36,6 -43,6 16.11% | -26,9 -36,8 26.82% | -35,7 -34,9 -2.25% | -36,4 -36,5 0.07% | -30,1 -33,7 10.59% | -74,0 -29,5 -150.74% | -23,6 -28,2 16.43% | -33,1 -12,6 -164.01% | -21,6 | -20,1 | -13,1 | -9,70 | |
|
EPS USD | Released Forecast Spread | 1,91 0,30 529.49% | -1,17 -1,40 16.5% | -0,84 -1,15 27.2% | -1,02 -1,07 4.65% | -0,99 -1,02 2.55% | -0,80 -0,94 14.81% | -1,94 -0,80 -143.89% | -0,57 -0,63 9.27% | -0,63 -0,25 -151.9% | -0,40 | -0,36 | -0,27 | -0,18 | -0,12 |
| Announcement Date | 09/03/22 | 05/05/22 | 04/08/22 | 09/11/22 | 08/03/23 | 04/05/23 | 03/08/23 | 02/11/23 | 28/02/24 | - | - | - | - | - |
More events
Past sector events for Mirum Pharmaceuticals, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- MIRM Stock
- Calendar Mirum Pharmaceuticals, Inc.
